MedPath

The effect of omega-3 fatty acids on the treatment of acute lung injury

Phase 2
Conditions
Acute lung injury.
Acute respiratory failure
Registration Number
IRCT2013020612387N1
Lead Sponsor
Vice chancellor for Research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
58
Inclusion Criteria

Patients with ALI criteria (Pao2/Fio2<250 and lung injury), less than 48 hours from their diagnosis. Exclusion criteria: Patients <18 years old, patients’ or their guardians’ unwillingness to participate, HIV, plasma TG >400, renal or liver failure, history of frequent transfusions, Thrombocytopenia (PLT<80000), Leukopenia (WBC<3000).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pao2/Fio2. Timepoint: On admission, seventh and fourteenth days. Method of measurement: Oxygenation, lung mechanic and inflammatory factors.
Secondary Outcome Measures
NameTimeMethod
Ventilator free days. Timepoint: On admission, seventh and fourteenth days. Method of measurement: Air way compliance and resistance is recorded.;Neutrophil peroxidation activity. Timepoint: On admission, seventh and fourteenth days. Method of measurement: After performing Mini- BAL, the fluid will be centrifuged and the debris will be removed. To measure the activity of neutrophil peroxidation, a marker of lung injury, the fluid will be sent to the laboratory.;Number of organ failure. Timepoint: On admission, seventh and fourteenth days. Method of measurement: Evaluation of various parameters such as clinical and blood serum factors.
© Copyright 2025. All Rights Reserved by MedPath